This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ERMA BTA Stock Overview

A pharmaceutical company, produces and supplies medical chewing gum and other nicotine products. More details

ERMA BTA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 18.7% per year over past 5 years

Shareholders have been substantially diluted in the past year

Makes less than USD$1m in revenue (SEK1M)

Shares are highly illiquid

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Enorama Pharma AB (publ) Competitors

AlzeCure Pharma

OM:ALZCUR

SEK 130.7m

Pila Pharma

OM:PILA

SEK 101.2m

Karolinska Development

OM:KDEV

SEK 277.9m

Annexin Pharmaceuticals

OM:ANNX

SEK 191.9m

Price History & Performance

Summary of share price highs, lows and changes for Enorama Pharma
Historical stock prices
Current Share Price	SEK 2.26
52 Week High	SEK 2.80
52 Week Low	SEK 2.10
Beta	1.54
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-8.87%

Recent updates

Shareholder Returns

	ERMA BTA	SE Pharmaceuticals	SE Market
7D	0%	6.4%	2.8%
1Y	n/a	17.7%	14.9%

Return vs Industry: Insufficient data to determine how ERMA BTA performed against the Swedish Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how ERMA BTA performed against the Swedish Market.

Price Volatility

Is ERMA BTA's price volatile compared to industry and market?
ERMA BTA volatility
ERMA BTA Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	5.7%
10% most volatile stocks in SE Market	12.0%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: ERMA BTA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ERMA BTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	9	Annette Agerskov	www.enorama.se

Enorama Pharma AB (publ), a pharmaceutical company, produces and supplies medical chewing gum and other nicotine products. It also offers nicotine pouches and medical cannabis products. Enorama Pharma AB (publ) was incorporated in 2006 and is based in Malmö, Sweden.

Enorama Pharma AB (publ) Fundamentals Summary

How do Enorama Pharma's earnings and revenue compare to its market cap?
ERMA BTA fundamental statistics
Market cap	SEK 133.83m
Earnings (TTM)	-SEK 44.61m
Revenue (TTM)	SEK 1.36m

98.5x

P/S Ratio

-3.0x

P/E Ratio

Is ERMA BTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ERMA BTA income statement (TTM)
Revenue	SEK 1.36m
Cost of Revenue	SEK 5.26m
Gross Profit	-SEK 3.90m
Other Expenses	SEK 40.71m
Earnings	-SEK 44.61m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-1.09
Gross Margin	-287.26%
Net Profit Margin	-3,285.20%
Debt/Equity Ratio	2.2%

How did ERMA BTA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/04/17 07:03
End of Day Share Price	2024/04/16 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Enorama Pharma AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Enorama Pharma OM:ERMA BTA Stock Report